Toronto, Ontario and London, United Kingdom–(Newsfile Corp. – August 26, 2024) – Britannia Life Sciences Inc. (CSE: BLAB) (FSE: L020) (“Britannia” or the “Company“) is providing an update on the status of the cease trade order (the “CTO“) imposed on August 2, 2024, by the Ontario Securities Commission (the “OSC“), under National Policy 11-207 (“NP 11-207“), following the Company’s failure to file its audited annual financial statements and related annual management’s discussion and analysis (“MD&A”) for the financial year ended March 31, 2024, as required under Part 4 and Part 5, respectively,…